| HSPMdb Accession No | HSPMDB002361 |
| PMID | 25944857 |
| Target | Hsp100 |
| HSP Name | ClpP1P2 |
| Organism | Bacteria |
| Localization | Cytosol |
| Cellular activity | Antibacterial activity |
| Compound Name | CEP-18770 (Delanzomib) |
| IUPAC Name | [(1R)-1-[[(2S,3R)-3-hydroxy-2-[(6-phenylpyridine-2-carbonyl)amino]butanoyl]amino]-3-methylbutyl]boronic acid |
| SMILES | B(C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C1=CC=CC(=N1)C2=CC=CC=C2)(O)O |
| Class | Bortezomib derivative |
| Site of Interaction | Nucleotide binding domain |
| Percentage Cell Growth Inhibition | 80% at 50 uM |
| Cellular assay | Bacterial growth inhibition assay (OD based) |
| Cellular Model | M. smegmatis (mc2155) |
| Disease | Tuberculosis |
Loading Please Wait ...